Home> Laws and Regulations

NMPA Issues Guidance for the Preservation of Essential Documents for Drug Clinical Trials

CCFDIE|Updated: 2020-06-08

To guide and regulate the preservation of essential documents for drug clinical trials, in accordance with the relevant regulations such as the Drug Administration Law, the Vaccine Administration Law, and theGood Clinical Practice, NMPA organized the formulation of the Guidance for the Preservation of Essential Documents for Drug Clinical Trials, which has been released on June 8, 2020 and shall come into effect as from July 1, 2020.